YHC · LQR House Inc.
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Jul 13, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Jul 13, 2026.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Beverages - Wineries & Distilleries — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
YHC
this stock
LQR House Inc.
|
$2.44M | — | +86.4% | — | 11.6% |
|
DEO
Diageo PLC
|
$52.17B | +9.7% | — | — | 0.7% |
|
BF-B
Brown Forman Corp
|
$13.04B | +9.1% | -1.2% | 18.6 | 0.2% |
|
APHD
Verde Bio Holdings, Inc.
|
$2.22B | +80.3% | -100.0% | — | 0.0% |
|
MGPI
Mgp Ingredients Inc
|
$385.32M | -25.7% | -13.5% | — | 4.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 0.5%
- Net QoQ
- +14 sh
- Top holder
- VANGUARD CAPITAL MANAGEME…
Performance
Raw-price comparisons begin at the captured split on Jul 13, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| YHC | +4.7% | -0.6% | — | -15.7% | — |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +6.1% | -4.2% | — | -18.2% | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.